13.05.2024 07:39:16 - dpa-AFX: *REGENERON: FDA ACCEPTS FOR PRIORITY REVIEW SBLA FOR DUPIXENT FOR CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS

Copyright(c) 2024 RTTNews.com. All Rights Reserved

Copyright RTT News/dpa-AFX
Name WKN Börse Kurs Datum/Zeit Diff. Diff. % Geld Brief Erster Schluss
SANOFI SA INHABER EO 2 920657 Xetra 90,140 27.06.24 15:03:35 -0,790 -0,87% 90,230 90,280 90,140 90,930
REGENERON PHARMAC.DL-,001 881535 Frankfurt 993,000 27.06.24 08:12:54 -13,500 -1,34% 998,000 1.009,500 993,000 1.006,500

© 2000-2024 DZ BANK AG. Bitte beachten Sie die Nutzungsbedingungen | Impressum
2024 Infront Financial Technology GmbH